Cognitive-Behavioral Therapy for Postbariatric Surgery Patients With Mental Disorders: A Pilot Study

Rudolph, Almut; Hilbert, Anja

doi:10.3389/fpsyt.2020.00014

Cited by 11 publications

(18 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These are heightened in the context of weight loss or cosmetic surgery where disordered behaviors such as irregular and binge eating if unchecked lead to adverse outcomes. Given the very high estimates found, such clinics may well benefit from staff with mental health expertise as people presenting for care may be reluctant to disclose ED symptoms on assessment questionnaires for fear they may not be offered the surgery [ 37 , 38 ]. However, the incorporation of a mental health assessment as a “routine” and the reassurance that mental health issues and EDs may be addressed prior to surgery can help to overcome this barrier to disclosure.…”

Section: Discussionmentioning

confidence: 99%

Bariatric and Cosmetic Surgery in People with Eating Disorders

et al. 2020

View full text Add to dashboard Cite

Rates of eating disorders (EDs) are increasing in Australia, as are rates of bariatric and cosmetic surgery including weight-related procedures. It is known that binge eating disorder (BED) is common in bariatric surgery candidates and that people with EDs are likely to undergo weight-related cosmetic procedures, however, most of the literature is based on clinic samples and focuses on young women and BED. Aims of this study were to determine the prevalence of (1) actual or intended bariatric surgery and (2) actual or intended cosmetic surgery including weight-related procedures in people with a current ED and a lifetime history of BED or bulimia nervosa (BN), and the associations with actual or intended bariatric or cosmetic surgery and demographic features. Using a general population survey, 2977 individuals were interviewed regarding sociodemographic status, ED symptoms, mental health-related quality of life (MHRQoL) and actual or intended use of bariatric and cosmetic surgery, prevalence estimates of which were 2.0% and 1.1%, respectively. People who had planned or received either type of surgery were more likely to be (1) women and (2) have a higher BMI, (3) poorer MHRQoL and (4) a current ED, lifetime BN or BED or features of EDs (all p < 0.05). Age and household income were not significantly associated with increased use of either type of surgery. Given the potential for an ED to affect outcomes of surgery, screening and treatment for EDs should be considered in such surgical candidates.

show abstract

Section: Discussionmentioning

confidence: 99%

Bariatric and Cosmetic Surgery in People with Eating Disorders

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Under-recognized psychological difficulties and under-treated mental health may negatively impact bariatric surgery outcomes (101). To this effect, weight recidivism-specific HL, specially formulated therapies targeting ED, maladaptive habits and behavioral clusters, specific emotion regulation strategies, and evidence-based psychological therapies for depression may be offered prior to and/or following bariatric surgery.…”

Section: Conclusion Limitations and Future Researchmentioning

confidence: 99%

The Clinical Obesity Maintenance Model: A Theoretical Framework for Bariatric Psychology

et al. 2020

View full text Add to dashboard Cite

Ranked highly in its association with serious medical comorbidities, obesity, a rapidly growing epidemic worldwide, poses a significant socioeconomic burden. While bariatric procedures offer the most efficacious treatment for weight loss, a subset of patients risk weight recidivism. Due to the heterogeneity of obesity, it is likely that there are phenotypes or subgroups of patients that require evidence-based psychological support to produce more sustainable outcomes. So far, however, characteristics of patients have not led to a personalized treatment algorithm for bariatric surgery. Maintenance of weight loss following bariatric surgery requires long-term modification of eating behaviors and physical activity. A recent Clinical Obesity Maintenance Model (COMM) proposed a conceptual framework of salient constructs, including the role of habit, behavioral clusters, emotion dysregulation, mood, health literacy, and executive function as interconnected drivers of obesity maintaining behaviors relevant to the field of bariatric psychology. The primary aim of this concise review is to bring together emerging findings from experimental and epidemiological studies relating to the COMM constructs that may inform the assessment and follow up of bariatric surgery. We also aim to explain the phenotypes that need to be understood and screened prior to bariatric surgery to enable better pre-surgery intervention and optimum post-surgery response.

show abstract

“…Venlafaxine overdoses are associated with a high risk of cardiac arrest. Frequent use of antidepressants in Australia, which had the third highest consumption of OECD countries in 2017 [ 41 ], may be explained by limited access to psychological counselling, overestimation of efficacy [ 42 ] and inadequate knowledge of risks [ 43 ]. When an antidepressant is needed, safer alternatives exist to those included in the “Drugs to Avoid” list, with similar efficacy levels, including other Selective Serotonin Reuptake Inhibitors (SSRIs) such as fluoxetine, fluvoxamine, or sertraline.…”

Section: Discussionmentioning

confidence: 99%

“Drugs to avoid” to improve quality use of medicines: how is Australia faring?

Vitry

Mintzes

2021

J of Pharm Policy and Pract

View full text Add to dashboard Cite

Background Each year, the French independent bulletin Prescrire publishes a list of medicines, “Drugs to avoid”, that should not be used in clinical practice as their risk-to-benefit ratio is unfavourable. This study assessed the market approval, reimbursement and use of these medicines in Australia. Methods The approval status of the medicines included in 2019 Prescrire “Drugs to avoid” list was assessed by searching the Australian Register of Therapeutic Goods website. Funding status was assessed on the Pharmaceutical Benefits Scheme (PBS) website, the Australian public insurance system. Use levels were determined by examining governmental reports on prescribing rates including the Australian Statistics on Medicines (ASM) reports, drug use reports released by the Drug Utilisation Sub Committee (DUSC) and PBS statistics. Results Of the 93 medicines included in the Prescrire 2019 “Drug to avoid” list included, 57 (61%) were approved in Australia in 2019 including 9 (16%) that were sold as over-the-counter medicines, 35 (38%) were listed on the PBS, 22 (24%) were registered but not listed on the PBS. Although most of these medicines were used infrequently, 16 (46%) had substantial use despite serious safety concerns. Dipeptidyl peptidase-4 (DPP-4) inhibitors were used by 22% of patients receiving a treatment for diabetes in 2016. More than 50,000 patients received an anti-dementia medicine in 2014, a 19% increase since 2009. Denosumab became the 8th medicine, in terms of total sales, funded by the Australian Government in 2017–2018. Conclusions Prescrire’s assessments provide a reliable external benchmark to assess the current use of medicines in Australia. Sixteen “drugs to avoid”, judged to be more harmful than beneficial based on systematic, independent evidence reviews, are in substantial use in Australia. These results raise serious concerns about the awareness of Australian clinicians of medicine safety and efficacy. Medicines safety has become an Australian National Health Priority. Regulatory and reimbursement agencies should review the marketing and funding status of medicines which have not been shown to provide an efficacy and safety at least similar to alternative therapeutic options.

show abstract

Cognitive-Behavioral Therapy for Postbariatric Surgery Patients With Mental Disorders: A Pilot Study

Cited by 11 publications

References 40 publications

Bariatric and Cosmetic Surgery in People with Eating Disorders

Bariatric and Cosmetic Surgery in People with Eating Disorders

The Clinical Obesity Maintenance Model: A Theoretical Framework for Bariatric Psychology

“Drugs to avoid” to improve quality use of medicines: how is Australia faring?

Contact Info

Product

Resources

About